0000950170-24-084655.txt : 20240718
0000950170-24-084655.hdr.sgml : 20240718
20240718171833
ACCESSION NUMBER: 0000950170-24-084655
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240716
FILED AS OF DATE: 20240718
DATE AS OF CHANGE: 20240718
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Freeman Roy Lester
CENTRAL INDEX KEY: 0001799732
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39676
FILM NUMBER: 241125461
MAIL ADDRESS:
STREET 1: 256 SUMMIT AVE
CITY: BROOKLINE
STATE: MA
ZIP: 02446
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inhibikase Therapeutics, Inc.
CENTRAL INDEX KEY: 0001750149
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 263407249
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3350 RIVERWOOD PARKWAY SE, SUITE 1900
CITY: ATLANTA
STATE: GA
ZIP: 30339
BUSINESS PHONE: 678-392-3419
MAIL ADDRESS:
STREET 1: 3350 RIVERWOOD PARKWAY SE, SUITE 1900
CITY: ATLANTA
STATE: GA
ZIP: 30339
4
1
ownership.xml
4
X0508
4
2024-07-16
0001750149
Inhibikase Therapeutics, Inc.
IKT
0001799732
Freeman Roy Lester
3350 RIVERWOOD PARKWAY SE, SUITE 1900
ATLANTA
GA
30339
true
false
false
false
false
Stock Option (right to buy)
1.54
2024-07-16
4
A
false
30000
0.00
A
2031-07-16
Common Stock
30000
30000
D
The options will vest on the earlier of July 16, 2025 or the day prior to the next annual meeting of stockholders, subject to the director's continued service through such date.
/s/ Milton H. Werner, attorney-in-fact
2024-07-18